SG Americas Securities
CAI

SG Americas Securities’s Caris Life Sciences CAI Stock Holding History

SG Americas Securities’s Portfolio CAI Stock Details CAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Buy
+152,236
New +$2.72M ﹤0.01% 1359

Other funds holding CAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ZCI
Zevenbergen Capital Investments Edmonds, Washington $4.38B AUM 56.68% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

SG Americas Securities's CAI Position: Q2 2026 in Review

SG Americas Securities opened a new position in Caris Life Sciences (CAI) in Q2 2026: 152,236 shares worth $2.71M. The stake represents ﹤0.01% of the portfolio and ranks #1359 among its holdings.

86 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • SG Americas Securities held 152,236 shares of Caris Life Sciences worth $2.71M as of Q2 2026.
  • Caris Life Sciences was a new SG Americas Securities position in Q2 2026.
  • Caris Life Sciences made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #1359 holding.
  • 86 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.